Pfizer and BioNTech have submitted their application to the US Food and Drug Administration for emergency use authorization of their bivalent Covid-19 vaccine for use in people age 12 and older, the companies said in a statement on Monday.
Pfizer and BioNTech have submitted their application to the US Food and Drug Administration for emergency use authorization of their bivalent Covid-19 vaccine for use in people age 12 and older, the companies said in a statement on Monday.